AXTZ:XETRA:XETRA-21Shares Tezos staking ETP (EUR)

COMMON STOCK | Others |

Last Closing

USD 5.0245

Change

+0.14 (+2.84)%

Market Cap

N/A

Volume

729.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
USUP:XETRA UBS(Lux)Fund Solutions – MSC..

+0.03 (+0.31%)

USD 1.07B
WEBH:XETRA Amundi MSCI USA UCITS ETF Acc ..

-0.01 (-0.03%)

USD 0.86B
CA1:XETRA Circus SE

+0.10 (+0.52%)

USD 0.51B
7V0:XETRA Darwin AG

N/A

USD 0.08B
ABCH:XETRA 21Shares Bitcoin Cash ETP

+0.20 (+1.58%)

N/A
TY3S:XETRA WisdomTree US Treasuries 10Y 3..

-0.39 (-0.37%)

N/A
42FB:XETRA AI/ML Innovations Inc.

N/A

N/A
8PSB:XETRA Invesco Physical Markets PLC O

-0.24 (-0.80%)

N/A
BTIC:XETRA Invesco Physical Bitcoin ETN E..

+0.83 (+0.91%)

N/A
BRNK:XETRA BRANICKS Group AG

+0.07 (+2.86%)

N/A

ETFs Containing AXTZ:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -32.33% 9% A- 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -32.33% 9% A- 1% F
Trailing 12 Months  
Capital Gain -10.98% 5% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.98% 5% F 30% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -9.79% 11% F 15% F
Dividend Return -9.79% 11% F 14% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 31.39% 56% F 46% F
Risk Adjusted Return -31.18% 11% F 17% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.